TTK and breast carcinoma: Furthermore, inhibition of Mps1 in p53-mutant breast cancer cells enhanced taxane treatment response through activation of the p53-dependent postmitotic spindle checkpoint as a result of loss of Mps1-mediated phosphorylation of p53 and MDM2-mediated p53 ubiquitination.123